No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4672016 |
chr2:55324960-55324961 |
Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs557928588 |
chr2:55324961-55324962 |
Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs79800828 |
chr2:55325001-55325002 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs533944670 |
chr2:55325044-55325045 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs145839248 |
chr2:55325121-55325122 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs573811512 |
chr2:55325133-55325134 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs542909818 |
chr2:55325189-55325190 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs372691457 |
chr2:55325245-55325246 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs148558013 |
chr2:55325257-55325258 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs575275574 |
chr2:55325297-55325298 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs544284786 |
chr2:55325338-55325339 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs564268709 |
chr2:55325339-55325340 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs528006452 |
chr2:55325362-55325363 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs4671239 |
chr2:55325372-55325373 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs2920875 |
chr2:55325385-55325386 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs567390574 |
chr2:55325414-55325415 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs536260552 |
chr2:55325520-55325521 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs373965234 |
chr2:55325536-55325537 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs188310783 |
chr2:55325544-55325545 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs191234100 |
chr2:55325560-55325561 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs549699526 |
chr2:55325580-55325581 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs185865077 |
chr2:55325616-55325617 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs142132704 |
chr2:55325619-55325620 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs190343717 |
chr2:55325637-55325638 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs7595814 |
chr2:55325639-55325640 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs570031952 |
chr2:55325677-55325678 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs533881810 |
chr2:55325719-55325720 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs553638179 |
chr2:55325741-55325742 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs146688770 |
chr2:55325749-55325750 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs115143863 |
chr2:55325751-55325752 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs556455841 |
chr2:55325758-55325759 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs575212635 |
chr2:55325839-55325840 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs182114437 |
chr2:55325855-55325856 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs559166737 |
chr2:55325863-55325864 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs572557038 |
chr2:55325868-55325869 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs7596128 |
chr2:55325911-55325912 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs2920876 |
chr2:55325912-55325913 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
38 |
rs186656081 |
chr2:55325926-55325927 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs2920877 |
chr2:55325927-55325928 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
40 |
rs529536269 |
chr2:55325942-55325943 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs190127454 |
chr2:55325943-55325944 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs181233653 |
chr2:55325945-55325946 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs532067624 |
chr2:55325947-55325948 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs551351173 |
chr2:55325999-55326000 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs534095816 |
chr2:55326017-55326018 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs571274470 |
chr2:55326033-55326034 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs533864703 |
chr2:55326045-55326046 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs573814848 |
chr2:55326109-55326110 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs2968810 |
chr2:55326133-55326134 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs567327549 |
chr2:55326178-55326179 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|